Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

about

Do single-arm trials have a role in drug development plans incorporating randomised trials?A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach.Comparison of single-arm vs. randomized phase II clinical trials: a Bayesian approach.

P2860

Q36866317-0F281B2A-2010-48EA-B937-CFDE88EF440C Q41643154-0434CDEE-7B69-461D-A119-F6779B78CD3F Q51081422-A604F490-FDB1-4A71-A23A-ED6647ABA215

P2860

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

Item

http://www.wikidata.org/entity/Q53083460

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@en

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@nl

type

Item

label

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@en

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@nl

prefLabel

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@en

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@nl

P1476

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

@en

P2093

Gregory R Pond

http://www.w3.org/2001/XMLSchema#string

Saqib Abbasi

http://www.w3.org/2001/XMLSchema#string

P2860

The price of innovation: new estimates of drug development costs

Admissible two-stage designs for phase II cancer clinical trials.

Current issues in oncology drug development, with a focus on Phase II trials

Content and quality of currently published phase II cancer trials.

Incorporating historical control data in planning phase II clinical trials.

Randomized phase II designs in cancer clinical trials: current status and future directions.

Economics of new oncology drug development.

Randomized phase II designs.

A comparison of phase II study strategies.

Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial.

P304

260-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774511401764

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21511687

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

about

P2860

P2860

Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921